FDC’s chooses UFlex’ Asepto holographic packaging for Electral
The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid
The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
Omicron patients below 60 with no comorbidities can start treatment with paracetamol
Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas
The acquisition would enable addition of established brands with high recall amongst healthcare professionals, especially in the vitamins, minerals and supplements category
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
Occupancy is expected to be in the range of 60-62% while Average Revenue Per Occupied Bed (ARPOB) is expected to expand by least 6% in FY2022
The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival
Subscribe To Our Newsletter & Stay Updated